Malden, MA, United States of America

Eric A Rowe


Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 182(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eric A Rowe: Innovator in Therapeutic Compositions

Introduction

Eric A Rowe is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of therapeutic compositions, particularly in the development of novel cationic amphiphiles and co-lipids. With a total of 3 patents, his work has the potential to impact gene therapy and the delivery of biologically active molecules.

Latest Patents

Rowe's latest patents include compositions comprising cationic amphiphiles and co-lipids. These innovative compositions typically consist of one or more neutral co-lipids and a cationic amphiphile. The therapeutic compositions are prepared by contacting a therapeutically active molecule with a dispersion of these components. Another significant patent involves cationic amphiphiles containing amino acids or derivatized amino acids. These amphiphiles facilitate the transport of therapeutic molecules, such as DNA, RNA, and polypeptides, into cells. The applications of these therapeutic compositions include gene therapy and the delivery of biologically active polypeptides to cells.

Career Highlights

Throughout his career, Eric A Rowe has worked with prominent organizations, including Genzyme Corporation and the University of Iowa Research Foundation. His experience in these institutions has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Rowe has collaborated with notable colleagues, including David J Harris and Edward R Lee. These partnerships have likely enhanced his research and development efforts in the field of therapeutic compositions.

Conclusion

Eric A Rowe's contributions to the field of therapeutic compositions demonstrate his innovative spirit and commitment to advancing medical science. His work in developing novel cationic amphiphiles and co-lipids holds promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…